BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35316115)

  • 1. Quality of Life in Patients With Recurrent and Second Primary Head and Neck Cancer.
    Ramprasad VH; Li J; Atchison K; Zandberg DP; Clump DA; Johnson JT; Nilsen ML
    Otolaryngol Head Neck Surg; 2023 Feb; 168(2):196-202. PubMed ID: 35316115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity and reliability of the Turkish version of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer.
    Senkal HA; Hayran M; Karakaya E; Yueh B; Weymuller EA; Hoşal AŞ
    Am J Otolaryngol; 2012; 33(4):417-26. PubMed ID: 22137146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
    Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
    Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Analysis of Caregiver Burden in Head and Neck Cancer.
    Kudrick LD; Baddour K; Wu R; Fadel M; Snyder V; Neopaney A; Thomas TH; Sabik LM; Nilsen ML; Johnson JT; Ferris RL; Nouraie SM; Hass R; Mady LJ
    JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):681-689. PubMed ID: 37318816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences and predictors of long-term quality of life in head and neck cancer survivors.
    El-Deiry MW; Futran ND; McDowell JA; Weymuller EA; Yueh B
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):380-4. PubMed ID: 19380361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural and Moroccan Validation of the University of Washington Quality of Life Questionnaire for Patients With Head and Neck Cancer.
    Adnane C; Oubahmane T; Adouly T; Elhani L; Rouadi S; Abada RL; Roubal M; Mahtar M
    Ann Otol Rhinol Laryngol; 2016 Feb; 125(2):151-9. PubMed ID: 26318159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-item screening question for fear of recurrence in head and neck cancer.
    Rogers SN; Cross B; Talwar C; Lowe D; Humphris G
    Eur Arch Otorhinolaryngol; 2016 May; 273(5):1235-42. PubMed ID: 25749490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease course after the first recurrence of head and neck squamous cell carcinoma following (chemo)radiation.
    de Ridder M; de Veij Mestdagh PD; Elbers JBW; Navran A; Zuur CL; Smeele LE; Al-Mamgani A
    Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):261-268. PubMed ID: 31602525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
    Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Korean version of the University of Washington Quality of Life Questionnaire for Patients with head and neck cancer, and its use in an initial validation study of 56 patients.
    Chang MY; Rogers SN; Lowe D; Jeong WJ; Cha W; Park KT; Kim DW; Chang H; Sung MW; Kim KH; Kwon TK
    Int J Oral Maxillofac Surg; 2012 Oct; 41(10):1201-5. PubMed ID: 22738627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'What will I be like' after my diagnosis of head and neck cancer?
    Rogers SN; Hogg ES; Cheung WK; Lai LK; Jassal P; Lowe D; Kanatas A
    Eur Arch Otorhinolaryngol; 2015 Sep; 272(9):2463-72. PubMed ID: 25047397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R).
    Weymuller EA; Alsarraf R; Yueh B; Deleyiannis FW; Coltrera MD
    Arch Otolaryngol Head Neck Surg; 2001 May; 127(5):489-93. PubMed ID: 11346422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neighborhood Deprivation and Symptoms, Psychological Distress, and Quality of Life Among Head and Neck Cancer Survivors.
    Balogun Z; Gardiner LA; Li J; Moroni EA; Rosenzweig M; Nilsen ML
    JAMA Otolaryngol Head Neck Surg; 2024 Apr; 150(4):295-302. PubMed ID: 38386337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancer.
    Vargo JA; Heron DE; Ferris RL; Rwigema JC; Wegner RE; Kalash R; Ohr J; Kubicek GJ; Burton S
    Radiother Oncol; 2012 Jul; 104(1):91-5. PubMed ID: 22677037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of dysphagia on quality of life after treatment of head-and-neck cancer.
    Nguyen NP; Frank C; Moltz CC; Vos P; Smith HJ; Karlsson U; Dutta S; Midyett A; Barloon J; Sallah S
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):772-8. PubMed ID: 15708256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between depressive symptoms, quality of life, and swallowing function in head and neck cancer patients 1 year after definitive therapy.
    Lin BM; Starmer HM; Gourin CG
    Laryngoscope; 2012 Jul; 122(7):1518-25. PubMed ID: 22467530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
    Xu MJ; Plonowska KA; Gurman ZR; Humphrey AK; Ha PK; Wang SJ; El-Sayed IH; Heaton CM; George JR; Yom SS; Algazi AP; Ryan WR
    Laryngoscope; 2020 Feb; 130(2):E48-E56. PubMed ID: 30919470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in head and neck cancer patients: impact of HPV and primary treatment modality.
    Maxwell JH; Mehta V; Wang H; Cunningham D; Duvvuri U; Kim S; Johnson JT; Ferris RL
    Laryngoscope; 2014 Jul; 124(7):1592-7. PubMed ID: 24353066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the Greek version of the University of Washington quality of life questionnaire for patients with head and neck cancer.
    Linardoutsos G; Rapidis AD; Lowe D; Bramis I; Rogers SN
    J Craniomaxillofac Surg; 2014 Jul; 42(5):601-7. PubMed ID: 24289872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced patient reported outcome measurement suitable for head and neck cancer follow-up clinics.
    Ghazali N; Lowe D; Rogers SN
    Head Neck Oncol; 2012 Jun; 4():32. PubMed ID: 22695251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.